Panacea Biotec Ltd.
•₹ 411.1-0.62%
2026-08-21
PROS
- Company is almost debt free
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 10.15x)
- Company generates healthy free cash flow
- Institutional investors have been accumulating - FII+DII up 2.3pp
CONS
- Company is loss-making at the operating / net level
- Recent results are weak - TTM profit is down 326.4% versus prior year
- Operating cash flow has been negative in recent years
- Company has a low return on equity of -1.7% over last 3 years
- Receivables are growing faster than sales - a possible quality concern
- Company has a low return on capital employed of 0.7%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | PANACEABIO | 402.75 | 0.00 | 2466.87 | 0.00 | 2.20 | -44.44 | 199.57 | 19.72 | -0.47 | 2.84 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 129 | 143 | 150 | 136 | 116 | 147 | 163 | 133 | 167 | 141 | 165 | 167 | 200 | |
| 140 | 147 | 151 | 142 | 130 | 140 | 156 | 159 | 168 | 159 | 153 | 164 | 203 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 6 | 3 | 6 | 11 | 4 | 5 | 4 | 9 | 6 | 6 | 2 | 3 | 4 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 |
| 13 | -8 | -2 | -2 | -17 | 5 | 4 | -0 | 7 | -19 | 6 | -1 | 4 | |
| Tax % | 15.73% | -6.56% | -33.33% | 6.13% | 6.86% | 1.05% | -1.37% | -4875.00% | 39.63% | 26.92% | 40.06% | 20.00% | 38.38% |
| Net Profit | 0 | 0 | 0 | 0 | -16 | 5 | 4 | -2 | 4 | -14 | 4 | -1 | 2 |
| 2 | -1 | -0 | -0 | -3 | 1 | 1 | -0 | 1 | -2 | 1 | 0 | 0 | |
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 129
- 140
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 1
- Depreciation
- 9
- 13
- Tax %
- 15.73%
- Net Profit
- 0
- 2
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 143
- 147
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 1
- Depreciation
- 9
- -8
- Tax %
- -6.56%
- Net Profit
- 0
- -1
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 150
- 151
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 1
- Depreciation
- 9
- -2
- Tax %
- -33.33%
- Net Profit
- 0
- -0
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 136
- 142
- Operating Profit
- —
- OPM %
- —
- Other Income
- 11
- Interest
- 1
- Depreciation
- 9
- -2
- Tax %
- 6.13%
- Net Profit
- 0
- -0
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 116
- 130
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 1
- Depreciation
- 9
- -17
- Tax %
- 6.86%
- Net Profit
- -16
- -3
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 147
- 140
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 1
- Depreciation
- 9
- 5
- Tax %
- 1.05%
- Net Profit
- 5
- 1
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 163
- 156
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 1
- Depreciation
- 9
- 4
- Tax %
- -1.37%
- Net Profit
- 4
- 1
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 133
- 159
- Operating Profit
- —
- OPM %
- —
- Other Income
- 9
- Interest
- 1
- Depreciation
- 8
- -0
- Tax %
- -4875.00%
- Net Profit
- -2
- -0
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 167
- 168
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 1
- Depreciation
- 8
- 7
- Tax %
- 39.63%
- Net Profit
- 4
- 1
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 141
- 159
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 2
- Depreciation
- 8
- -19
- Tax %
- 26.92%
- Net Profit
- -14
- -2
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 165
- 153
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 2
- Depreciation
- 8
- 6
- Tax %
- 40.06%
- Net Profit
- 4
- 1
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 167
- 164
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 1
- Depreciation
- 8
- -1
- Tax %
- 20.00%
- Net Profit
- -1
- 0
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 200
- 203
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 1
- Depreciation
- 8
- 4
- Tax %
- 38.38%
- Net Profit
- 2
- 0
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 6
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 653 | 544 | 593 | 457 | 544 | 625 | 661 | 460 | 559 | 559 | 673 | |
| 541 | 497 | 508 | 590 | 519 | 548 | 674 | 558 | 579 | 585 | 680 | |
| Operating Profit | 132 | 94 | 93 | -128 | 56 | 87 | -2 | -46 | 6 | -5 | — |
| OPM % | 20 | 17 | 16 | -28 | 10 | 14 | -0 | -10 | 1 | -1 | — |
| Other Income | 20 | 47 | 8 | 5 | 30 | 10 | 11 | 52 | 26 | 21 | 15 |
| Interest | 127 | 101 | 101 | 105 | 174 | 185 | 181 | 4 | 4 | 4 | 6 |
| Depreciation | 73 | 68 | 59 | 55 | 44 | 46 | 44 | 39 | 37 | 35 | 33 |
| -19 | -67 | -66 | 46 | -178 | -144 | 1,449 | 13 | 1 | -8 | -10 | |
| Tax % | -10 | 16 | -15 | 19 | -10 | -1 | 26 | 364 | 202 | -10 | 14 |
| Net Profit | -21 | -56 | -76 | 38 | -195 | -146 | 1,078 | -34 | -2 | -9 | -9 |
| EPS | 0 | 0 | 0 | 0 | 0 | -24 | 176 | -5 | -0 | -1 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 2 | 2 | 2 | 0 | 0 | -0 | -0 | 1 | 0 | 0 | -0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -3 | -9 | -12 | 6 | -32 | -24 | 176 | -5 | -0 | -1 | — |
| Minority Interest | 2 | 2 | 2 | 0 | 0 | -0 | -0 | 1 | 0 | 0 | -0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -3 | -9 | -12 | 6 | -32 | -24 | 176 | -5 | -0 | -1 | — |
Mar 2016
- 653
- 541
- Operating Profit
- 132
- OPM %
- 20
- Other Income
- 20
- Interest
- 127
- Depreciation
- 73
- -19
- Tax %
- -10
- Net Profit
- -21
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 2
- Share of Associates
- 0
- Adjusted EPS
- -3
- Minority Interest
- 2
- Share of Associates
- 0
- Adjusted EPS
- -3
Mar 2017
- 544
- 497
- Operating Profit
- 94
- OPM %
- 17
- Other Income
- 47
- Interest
- 101
- Depreciation
- 68
- -67
- Tax %
- 16
- Net Profit
- -56
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 2
- Share of Associates
- 0
- Adjusted EPS
- -9
- Minority Interest
- 2
- Share of Associates
- 0
- Adjusted EPS
- -9
Mar 2018
- 593
- 508
- Operating Profit
- 93
- OPM %
- 16
- Other Income
- 8
- Interest
- 101
- Depreciation
- 59
- -66
- Tax %
- -15
- Net Profit
- -76
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 2
- Share of Associates
- 0
- Adjusted EPS
- -12
- Minority Interest
- 2
- Share of Associates
- 0
- Adjusted EPS
- -12
Mar 2019
- 457
- 590
- Operating Profit
- -128
- OPM %
- -28
- Other Income
- 5
- Interest
- 105
- Depreciation
- 55
- 46
- Tax %
- 19
- Net Profit
- 38
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2020
- 544
- 519
- Operating Profit
- 56
- OPM %
- 10
- Other Income
- 30
- Interest
- 174
- Depreciation
- 44
- -178
- Tax %
- -10
- Net Profit
- -195
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -32
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -32
Mar 2021
- 625
- 548
- Operating Profit
- 87
- OPM %
- 14
- Other Income
- 10
- Interest
- 185
- Depreciation
- 46
- -144
- Tax %
- -1
- Net Profit
- -146
- EPS
- -24
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- -24
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- -24
Mar 2022
- 661
- 674
- Operating Profit
- -2
- OPM %
- -0
- Other Income
- 11
- Interest
- 181
- Depreciation
- 44
- 1,449
- Tax %
- 26
- Net Profit
- 1,078
- EPS
- 176
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 176
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 176
Mar 2023
- 460
- 558
- Operating Profit
- -46
- OPM %
- -10
- Other Income
- 52
- Interest
- 4
- Depreciation
- 39
- 13
- Tax %
- 364
- Net Profit
- -34
- EPS
- -5
- Dividend Payout %
- 0
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- -5
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- -5
Mar 2024
- 559
- 579
- Operating Profit
- 6
- OPM %
- 1
- Other Income
- 26
- Interest
- 4
- Depreciation
- 37
- 1
- Tax %
- 202
- Net Profit
- -2
- EPS
- -0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
Mar 2025
- 559
- 585
- Operating Profit
- -5
- OPM %
- -1
- Other Income
- 21
- Interest
- 4
- Depreciation
- 35
- -8
- Tax %
- -10
- Net Profit
- -9
- EPS
- -1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -1
TTM
- 673
- 680
- Operating Profit
- —
- OPM %
- —
- Other Income
- 15
- Interest
- 6
- Depreciation
- 33
- -10
- Tax %
- 14
- Net Profit
- -9
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- -2%
- 5 Years:
- 1%
- 3 Years:
- -5%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- 14%
- 5 Years:
- 6%
- 3 Years:
- 46%
- 1 Year:
- 1%
RETURN ON EQUITY
- 10 Years:
- 21%
- 5 Years:
- 66%
- 3 Years:
- -2%
- Last Year:
- -1%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | |
| 426 | 350 | 303 | 344 | 161 | -235 | 871 | 837 | 836 | 829 | |
| 192 | 280 | 370 | 600 | 129 | 84 | 0 | 0 | 0 | 0 | |
| Trade Payables | 188 | 249 | 277 | 270 | 199 | 247 | 235 | 177 | 146 | 226 |
| 1,213 | 890 | 636 | 135 | 1,064 | 1,075 | 624 | 422 | 425 | 241 | |
| Total Liabilities | 2,025 | 1,774 | 1,592 | 1,356 | 1,559 | 1,177 | 1,735 | 1,443 | 1,412 | 1,301 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 1,071 | 1,001 | 949 | 806 | 657 | 609 | 622 | 600 | 569 | 551 | |
| Capital Work in Progress | 105 | 9 | 8 | 8 | 10 | 21 | 5 | 28 | 75 | 94 |
| 9 | 7 | 7 | 5 | 6 | 0 | 5 | 13 | 40 | 3 | |
| 305 | 316 | 334 | 81 | 148 | 174 | 213 | 202 | 178 | 214 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 57 | 73 | |
| Cash & Bank | 23 | 14 | 23 | 23 | 90 | 136 | 583 | 226 | 122 | 107 |
| 511 | 427 | 271 | 432 | 649 | 237 | 307 | 373 | 371 | 260 | |
| Total Assets | 2,025 | 1,774 | 1,592 | 1,356 | 1,559 | 1,177 | 1,735 | 1,443 | 1,412 | 1,301 |
| Total Debt | 1,088 | 994 | 941 | 646 | 742 | 820 | 34 | 20 | 21 | 22 |
| Net Working Capital | 75 | 14 | -131 | -430 | 61 | 27 | 177 | 233 | 176 | 178 |
| Contingent Liabilities | 354 | 364 | 379 | 404 | 367 | 407 | 368 | 656 | 369 | 367 |
| Book Value per Share | -4.43 | 58.07 | 50.40 | 57.21 | 27.23 | -37.34 | 143.12 | 137.73 | 137.48 | 136.29 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Debt | 1,088 | 994 | 941 | 646 | 742 | 820 | 34 | 20 | 21 | 22 |
| Net Working Capital | 75 | 14 | -131 | -430 | 61 | 27 | 177 | 233 | 176 | 178 |
| Contingent Liabilities | 354 | 364 | 379 | 404 | 367 | 407 | 368 | 656 | 369 | 367 |
| Book Value per Share | -4.43 | 58.07 | 50.40 | 57.21 | 27.23 | -37.34 | 143.12 | 137.73 | 137.48 | 136.29 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Mar 2016
- 6
- 426
- 192
- Trade Payables
- 188
- 1,213
- Total Liabilities
- 2,025
- 1,071
- Capital Work in Progress
- 105
- 9
- 305
- 0
- Cash & Bank
- 23
- 511
- Total Assets
- 2,025
- Total Debt
- 1,088
- Net Working Capital
- 75
- Contingent Liabilities
- 354
- Book Value per Share
- -4.43
- Face Value
- 1.00
- Total Debt
- 1,088
- Net Working Capital
- 75
- Contingent Liabilities
- 354
- Book Value per Share
- -4.43
- Face Value
- 1.00
Mar 2017
- 6
- 350
- 280
- Trade Payables
- 249
- 890
- Total Liabilities
- 1,774
- 1,001
- Capital Work in Progress
- 9
- 7
- 316
- 0
- Cash & Bank
- 14
- 427
- Total Assets
- 1,774
- Total Debt
- 994
- Net Working Capital
- 14
- Contingent Liabilities
- 364
- Book Value per Share
- 58.07
- Face Value
- 1.00
- Total Debt
- 994
- Net Working Capital
- 14
- Contingent Liabilities
- 364
- Book Value per Share
- 58.07
- Face Value
- 1.00
Mar 2018
- 6
- 303
- 370
- Trade Payables
- 277
- 636
- Total Liabilities
- 1,592
- 949
- Capital Work in Progress
- 8
- 7
- 334
- 0
- Cash & Bank
- 23
- 271
- Total Assets
- 1,592
- Total Debt
- 941
- Net Working Capital
- -131
- Contingent Liabilities
- 379
- Book Value per Share
- 50.40
- Face Value
- 1.00
- Total Debt
- 941
- Net Working Capital
- -131
- Contingent Liabilities
- 379
- Book Value per Share
- 50.40
- Face Value
- 1.00
Mar 2019
- 6
- 344
- 600
- Trade Payables
- 270
- 135
- Total Liabilities
- 1,356
- 806
- Capital Work in Progress
- 8
- 5
- 81
- 0
- Cash & Bank
- 23
- 432
- Total Assets
- 1,356
- Total Debt
- 646
- Net Working Capital
- -430
- Contingent Liabilities
- 404
- Book Value per Share
- 57.21
- Face Value
- 1.00
- Total Debt
- 646
- Net Working Capital
- -430
- Contingent Liabilities
- 404
- Book Value per Share
- 57.21
- Face Value
- 1.00
Mar 2020
- 6
- 161
- 129
- Trade Payables
- 199
- 1,064
- Total Liabilities
- 1,559
- 657
- Capital Work in Progress
- 10
- 6
- 148
- 0
- Cash & Bank
- 90
- 649
- Total Assets
- 1,559
- Total Debt
- 742
- Net Working Capital
- 61
- Contingent Liabilities
- 367
- Book Value per Share
- 27.23
- Face Value
- 1.00
- Total Debt
- 742
- Net Working Capital
- 61
- Contingent Liabilities
- 367
- Book Value per Share
- 27.23
- Face Value
- 1.00
Mar 2021
- 6
- -235
- 84
- Trade Payables
- 247
- 1,075
- Total Liabilities
- 1,177
- 609
- Capital Work in Progress
- 21
- 0
- 174
- 0
- Cash & Bank
- 136
- 237
- Total Assets
- 1,177
- Total Debt
- 820
- Net Working Capital
- 27
- Contingent Liabilities
- 407
- Book Value per Share
- -37.34
- Face Value
- 1.00
- Total Debt
- 820
- Net Working Capital
- 27
- Contingent Liabilities
- 407
- Book Value per Share
- -37.34
- Face Value
- 1.00
Mar 2022
- 6
- 871
- 0
- Trade Payables
- 235
- 624
- Total Liabilities
- 1,735
- 622
- Capital Work in Progress
- 5
- 5
- 213
- 0
- Cash & Bank
- 583
- 307
- Total Assets
- 1,735
- Total Debt
- 34
- Net Working Capital
- 177
- Contingent Liabilities
- 368
- Book Value per Share
- 143.12
- Face Value
- 1.00
- Total Debt
- 34
- Net Working Capital
- 177
- Contingent Liabilities
- 368
- Book Value per Share
- 143.12
- Face Value
- 1.00
Mar 2023
- 6
- 837
- 0
- Trade Payables
- 177
- 422
- Total Liabilities
- 1,443
- 600
- Capital Work in Progress
- 28
- 13
- 202
- 0
- Cash & Bank
- 226
- 373
- Total Assets
- 1,443
- Total Debt
- 20
- Net Working Capital
- 233
- Contingent Liabilities
- 656
- Book Value per Share
- 137.73
- Face Value
- 1.00
- Total Debt
- 20
- Net Working Capital
- 233
- Contingent Liabilities
- 656
- Book Value per Share
- 137.73
- Face Value
- 1.00
Mar 2024
- 6
- 836
- 0
- Trade Payables
- 146
- 425
- Total Liabilities
- 1,412
- 569
- Capital Work in Progress
- 75
- 40
- 178
- 57
- Cash & Bank
- 122
- 371
- Total Assets
- 1,412
- Total Debt
- 21
- Net Working Capital
- 176
- Contingent Liabilities
- 369
- Book Value per Share
- 137.48
- Face Value
- 1.00
- Total Debt
- 21
- Net Working Capital
- 176
- Contingent Liabilities
- 369
- Book Value per Share
- 137.48
- Face Value
- 1.00
Mar 2025
- 6
- 829
- 0
- Trade Payables
- 226
- 241
- Total Liabilities
- 1,301
- 551
- Capital Work in Progress
- 94
- 3
- 214
- 73
- Cash & Bank
- 107
- 260
- Total Assets
- 1,301
- Total Debt
- 22
- Net Working Capital
- 178
- Contingent Liabilities
- 367
- Book Value per Share
- 136.29
- Face Value
- 1.00
- Total Debt
- 22
- Net Working Capital
- 178
- Contingent Liabilities
- 367
- Book Value per Share
- 136.29
- Face Value
- 1.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 91 | 131 | 118 | 105 | -30 | 107 | -108 | -422 | 3 | -27 | |
| Cash from Investing | 16 | -26 | 55 | -5 | -35 | -48 | 1,283 | 430 | 7 | 65 |
| Cash from Financing | -117 | -107 | -164 | -101 | 91 | -47 | -1,176 | -18 | -3 | -3 |
| -10 | -2 | 9 | -2 | 26 | 12 | -2 | -10 | 7 | 35 | |
| Free Cash Flow | 91 | 131 | 113 | 105 | -30 | 107 | -140 | -462 | -24 | -62 |
| OCF / Net Profit | -4.35 | -2.31 | -1.55 | 2.79 | 0.16 | -0.73 | -0.10 | 12.52 | -2.30 | 3.14 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 409 | 425 | 155 | -421 | -550 | -582 |
| OCF / Net Profit | -4.35 | -2.31 | -1.55 | 2.79 | 0.16 | -0.73 | -0.10 | 12.52 | -2.30 | 3.14 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 409 | 425 | 155 | -421 | -550 | -582 |
Mar 2016
- 91
- Cash from Investing
- 16
- Cash from Financing
- -117
- -10
- Free Cash Flow
- 91
- OCF / Net Profit
- -4.35
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -4.35
- Cumulative 5-Year FCF
- 0
Mar 2017
- 131
- Cash from Investing
- -26
- Cash from Financing
- -107
- -2
- Free Cash Flow
- 131
- OCF / Net Profit
- -2.31
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -2.31
- Cumulative 5-Year FCF
- 0
Mar 2018
- 118
- Cash from Investing
- 55
- Cash from Financing
- -164
- 9
- Free Cash Flow
- 113
- OCF / Net Profit
- -1.55
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.55
- Cumulative 5-Year FCF
- 0
Mar 2019
- 105
- Cash from Investing
- -5
- Cash from Financing
- -101
- -2
- Free Cash Flow
- 105
- OCF / Net Profit
- 2.79
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.79
- Cumulative 5-Year FCF
- 0
Mar 2020
- -30
- Cash from Investing
- -35
- Cash from Financing
- 91
- 26
- Free Cash Flow
- -30
- OCF / Net Profit
- 0.16
- Cumulative 5-Year FCF
- 409
- OCF / Net Profit
- 0.16
- Cumulative 5-Year FCF
- 409
Mar 2021
- 107
- Cash from Investing
- -48
- Cash from Financing
- -47
- 12
- Free Cash Flow
- 107
- OCF / Net Profit
- -0.73
- Cumulative 5-Year FCF
- 425
- OCF / Net Profit
- -0.73
- Cumulative 5-Year FCF
- 425
Mar 2022
- -108
- Cash from Investing
- 1,283
- Cash from Financing
- -1,176
- -2
- Free Cash Flow
- -140
- OCF / Net Profit
- -0.10
- Cumulative 5-Year FCF
- 155
- OCF / Net Profit
- -0.10
- Cumulative 5-Year FCF
- 155
Mar 2023
- -422
- Cash from Investing
- 430
- Cash from Financing
- -18
- -10
- Free Cash Flow
- -462
- OCF / Net Profit
- 12.52
- Cumulative 5-Year FCF
- -421
- OCF / Net Profit
- 12.52
- Cumulative 5-Year FCF
- -421
Mar 2024
- 3
- Cash from Investing
- 7
- Cash from Financing
- -3
- 7
- Free Cash Flow
- -24
- OCF / Net Profit
- -2.30
- Cumulative 5-Year FCF
- -550
- OCF / Net Profit
- -2.30
- Cumulative 5-Year FCF
- -550
Mar 2025
- -27
- Cash from Investing
- 65
- Cash from Financing
- -3
- 35
- Free Cash Flow
- -62
- OCF / Net Profit
- 3.14
- Cumulative 5-Year FCF
- -582
- OCF / Net Profit
- 3.14
- Cumulative 5-Year FCF
- -582
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | -2.98 | -8.90 | -12.08 | 6.16 | -31.72 | -24.11 | 176.05 | -5.43 | -0.19 | -1.37 |
| Book Value (₹) | -4.43 | 58.07 | 50.40 | 57.21 | 27.23 | -37.34 | 143.12 | 137.73 | 137.48 | 136.29 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 8.56 | 1.87 | -2.89 | 15.11 | -24.57 | -16.43 | 183.20 | 0.88 | 5.75 | 4.26 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 20.21% | 16.80% | 15.56% | -28.04% | 10.26% | 13.22% | -0.32% | -9.77% | -3.53% | -4.61% |
| Net Margin % | -3.19% | -10.12% | -12.78% | 8.22% | -35.77% | -22.32% | 155.09% | -7.12% | -0.26% | -1.55% |
| ROE % | 0.00% | -34.38% | -22.94% | 11.39% | -75.26% | 0.00% | 332.85% | -3.92% | -0.18% | -1.04% |
| ROCE % | 9.93% | 2.76% | 2.63% | 13.44% | -0.38% | 5.36% | 217.12% | 1.94% | 0.59% | -0.47% |
| -1.01% | -2.97% | -4.53% | 2.55% | -13.36% | -10.69% | 74.05% | -2.12% | -0.11% | -0.64% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 67 | 93 | 85 | 90 | 53 | 43 | 44 | 55 | 38 | 42 |
| Inventory Days | 172 | 203 | 199 | 166 | 77 | 90 | 102 | 160 | 122 | 127 |
| Payable Days | 336 | 533 | 512 | 579 | 545 | 397 | 335 | 298 | 256 | 340 |
| -97 | -237 | -228 | -324 | -416 | -265 | -190 | -83 | -96 | -170 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | -100.22x | 2.79x | 3.05x | 1.84x | 4.45x | -3.58x | 0.04x | 0.02x | 0.02x | 0.03x |
| Interest Coverage (x) | 0.85x | 0.33x | 0.34x | 1.44x | -0.02x | 0.22x | 9.01x | 3.89x | 1.41x | -1.05x |
| 1.16x | 1.02x | 0.81x | 0.54x | 1.10x | 1.06x | 1.23x | 1.71x | 1.57x | 1.49x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | -4.96% | -16.70% | 8.97% | -22.96% | 19.13% | 14.84% | 5.83% | -30.44% | 21.57% | -0.01% |
| Operating Profit Growth % | 82.50% | -29.04% | -1.01% | -238.06% | 143.60% | 55.10% | -102.58% | -1972.34% | 112.39% | -191.58% |
| Net Profit Growth % | 79.66% | -170.84% | -34.95% | 149.23% | -618.75% | 24.88% | 837.56% | -103.13% | 95.54% | -479.34% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 96.47% | -613.58% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.88x | 3.23x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 111.94x | -497.76x |
Mar 2016
- EPS (₹)
- -2.98
- Book Value (₹)
- -4.43
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.56
- Operating Margin %
- 20.21%
- Net Margin %
- -3.19%
- ROE %
- 0.00%
- ROCE %
- 9.93%
- -1.01%
- Debtor Days
- 67
- Inventory Days
- 172
- Payable Days
- 336
- -97
- Debt to Equity (x)
- -100.22x
- Interest Coverage (x)
- 0.85x
- 1.16x
- Revenue Growth %
- -4.96%
- Operating Profit Growth %
- 82.50%
- Net Profit Growth %
- 79.66%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- -8.90
- Book Value (₹)
- 58.07
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.87
- Operating Margin %
- 16.80%
- Net Margin %
- -10.12%
- ROE %
- -34.38%
- ROCE %
- 2.76%
- -2.97%
- Debtor Days
- 93
- Inventory Days
- 203
- Payable Days
- 533
- -237
- Debt to Equity (x)
- 2.79x
- Interest Coverage (x)
- 0.33x
- 1.02x
- Revenue Growth %
- -16.70%
- Operating Profit Growth %
- -29.04%
- Net Profit Growth %
- -170.84%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- -12.08
- Book Value (₹)
- 50.40
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -2.89
- Operating Margin %
- 15.56%
- Net Margin %
- -12.78%
- ROE %
- -22.94%
- ROCE %
- 2.63%
- -4.53%
- Debtor Days
- 85
- Inventory Days
- 199
- Payable Days
- 512
- -228
- Debt to Equity (x)
- 3.05x
- Interest Coverage (x)
- 0.34x
- 0.81x
- Revenue Growth %
- 8.97%
- Operating Profit Growth %
- -1.01%
- Net Profit Growth %
- -34.95%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 6.16
- Book Value (₹)
- 57.21
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 15.11
- Operating Margin %
- -28.04%
- Net Margin %
- 8.22%
- ROE %
- 11.39%
- ROCE %
- 13.44%
- 2.55%
- Debtor Days
- 90
- Inventory Days
- 166
- Payable Days
- 579
- -324
- Debt to Equity (x)
- 1.84x
- Interest Coverage (x)
- 1.44x
- 0.54x
- Revenue Growth %
- -22.96%
- Operating Profit Growth %
- -238.06%
- Net Profit Growth %
- 149.23%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- -31.72
- Book Value (₹)
- 27.23
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -24.57
- Operating Margin %
- 10.26%
- Net Margin %
- -35.77%
- ROE %
- -75.26%
- ROCE %
- -0.38%
- -13.36%
- Debtor Days
- 53
- Inventory Days
- 77
- Payable Days
- 545
- -416
- Debt to Equity (x)
- 4.45x
- Interest Coverage (x)
- -0.02x
- 1.10x
- Revenue Growth %
- 19.13%
- Operating Profit Growth %
- 143.60%
- Net Profit Growth %
- -618.75%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- -24.11
- Book Value (₹)
- -37.34
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -16.43
- Operating Margin %
- 13.22%
- Net Margin %
- -22.32%
- ROE %
- 0.00%
- ROCE %
- 5.36%
- -10.69%
- Debtor Days
- 43
- Inventory Days
- 90
- Payable Days
- 397
- -265
- Debt to Equity (x)
- -3.58x
- Interest Coverage (x)
- 0.22x
- 1.06x
- Revenue Growth %
- 14.84%
- Operating Profit Growth %
- 55.10%
- Net Profit Growth %
- 24.88%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 176.05
- Book Value (₹)
- 143.12
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 183.20
- Operating Margin %
- -0.32%
- Net Margin %
- 155.09%
- ROE %
- 332.85%
- ROCE %
- 217.12%
- 74.05%
- Debtor Days
- 44
- Inventory Days
- 102
- Payable Days
- 335
- -190
- Debt to Equity (x)
- 0.04x
- Interest Coverage (x)
- 9.01x
- 1.23x
- Revenue Growth %
- 5.83%
- Operating Profit Growth %
- -102.58%
- Net Profit Growth %
- 837.56%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- -5.43
- Book Value (₹)
- 137.73
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.88
- Operating Margin %
- -9.77%
- Net Margin %
- -7.12%
- ROE %
- -3.92%
- ROCE %
- 1.94%
- -2.12%
- Debtor Days
- 55
- Inventory Days
- 160
- Payable Days
- 298
- -83
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 3.89x
- 1.71x
- Revenue Growth %
- -30.44%
- Operating Profit Growth %
- -1972.34%
- Net Profit Growth %
- -103.13%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- -0.19
- Book Value (₹)
- 137.48
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.75
- Operating Margin %
- -3.53%
- Net Margin %
- -0.26%
- ROE %
- -0.18%
- ROCE %
- 0.59%
- -0.11%
- Debtor Days
- 38
- Inventory Days
- 122
- Payable Days
- 256
- -96
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 1.41x
- 1.57x
- Revenue Growth %
- 21.57%
- Operating Profit Growth %
- 112.39%
- Net Profit Growth %
- 95.54%
- 96.47%
- P/E (x)
- 0.00x
- P/B (x)
- 0.88x
- Dividend Yield %
- 0.00%
- 111.94x
Mar 2025
- EPS (₹)
- -1.37
- Book Value (₹)
- 136.29
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.26
- Operating Margin %
- -4.61%
- Net Margin %
- -1.55%
- ROE %
- -1.04%
- ROCE %
- -0.47%
- -0.64%
- Debtor Days
- 42
- Inventory Days
- 127
- Payable Days
- 340
- -170
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- -1.05x
- 1.49x
- Revenue Growth %
- -0.01%
- Operating Profit Growth %
- -191.58%
- Net Profit Growth %
- -479.34%
- -613.58%
- P/E (x)
- 0.00x
- P/B (x)
- 3.23x
- Dividend Yield %
- 0.00%
- -497.76x
Documents
Announcements
- Copy of Newspaper Publication
2026-08-18 - Panacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication
- Copy of Newspaper Publication
2026-08-14 - Panacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication
Annual Reports
Credit Ratings
Nothing filed yet.